Netherlands· NL-0e22021dcb55
Gutron 5 mg, tabletten
A midodrine product containing midodrinehydrochloride, registered in Netherlands by Euro Registratie Collectief B.V.. The same ATC class is registered in 15 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Midodrine is registered in 15 of 19 countries.
Countries holding a registration under ATC C01CA17 (midodrine), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Midodrine · ATC C01CA17
15 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of midodrine costs, country by country.
Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.67 in United States to $9.42 in Switzerland — a ×14 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Midodrine · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- CH Switzerland$9.42
- FR France$2.73
- US United States$0.67 (acquisition cost)
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- MIDODRINEHYDROCHLORIDE
- Manufacturer
- Euro Registratie Collectief B.V.
- Country
- Netherlands (NL)
- ATC code
- C01CA17
- ATC class
- Midodrine
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id118685//16514
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
115 interactions on record for midodrine.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Midodrine · interactions on record
115 records
- 2 severe
- 84 moderate
- 3 minor
- 26 info
Most severe, free to view
- Iobenguane (123I)V09IX01severe
- Iobenguane (131I)V09IX02severe
- EpinephrineA01AD01moderate
- TrospiumA03AB20moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Midodrine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMidodrine hydrochlorideZydus Lifesciences Limited
- United KingdomBramox 5mg tabletsBrancaster Pharma Ltd
- SwedenAugermid 5 mg TablettAspire Pharma (Malta) Limited
- IrelandMidodrine Hydrochloride Aspire 5 mg tabletsAspire Pharma (Malta) Limited
- CanadaAPO-MIDODRINEAPOTEX INC
- IcelandHypotronBrancaster Pharma Ireland Ltd.
- CzechiaGUTRONCHEPLAPHARM Arzneimittel GmbH, Greifswald
- SwitzerlandMidodrin Substipharm 5 mg, comprimésLeman SKL SA
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Gutron
- Bulgaria · Гутрон
- Cyprus · Midodrine Tillomed
- Czechia · Gutron
- Germany · Gutron
- Denmark · Augermid, Hypotron
- Spain · Gutron
- Finland · Hypotron, Midodrine Tillomed
- France · Gutron, Midodrine Arrow
- United Kingdom (Northern Ireland) · Bramox, Midodrine
- Greece · Midodrine Tillomed
- Hungary · Gutron
- Ireland · Midodrine Hydrochloride Aspire, Midodrine Tillomed
- Iceland · Hypotron, Midodrin Evolan
- Italy · Gutron
- Norway · Augermid, Hypotron
- Poland · Gutron
- Portugal · Gutron
- Romania · Gutron
- Sweden · Augermid, Hypotron
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aa6576c1-6eb6-40d9-99bd-fb7dc1a573b1 GET /v1/drugs/aa6576c1-6eb6-40d9-99bd-fb7dc1a573b1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h16514_smpc.pdf",
"strength": null,
"atc_label": "Midodrine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg118685",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"MAGNESIUMSTEARAAT (E 470b)",
"MAÏSZETMEEL",
"SILICIUMDIOXIDE (E 551)",
"TALK (E 553b)",
"ZONNEGEEL FCF ALUMINIUMLAK (E 110)"
],
"substances": [
"MIDODRINEHYDROCHLORIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h118685.pdf",
"authorised_at": "2016/02/24",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "118685//16514",
"additional_monitoring": "N"
}See everything about midodrine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.